NCT02816112View on ClinicalTrials.gov

Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia

PHASE4CompletedINTERVENTIONAL
Enrollment

458

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

March 31, 2020

Study Completion Date

April 30, 2020

Conditions
Early Stage Breast Cancer
Interventions
DRUG

Ciprofloxacin

Antibiotic

DRUG

Neupogen

Granulocyte-colony stimulating factor

Trial Locations (1)

Unknown

The Ottawa Hospital Research Institute, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER